Cytokinetics Inc
CYTK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.46B
Close$
$-13.33
122.8% downside
Current Fair Value
122.8% downsideOvervalued by 122.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.46 Billion |
|---|---|
| Enterprise Value | $8.53 Billion |
| Earnings per Share | $-6.54 |
| Beta | 0.36 |
| Outstanding Shares | 139,045,000 |
Return
| Return on Equity | 242.21% |
|---|---|
| Return on Assets | -42.63% |
| Return on Invested Capital | -48.96% |
Valuation & Multiples
| P/E Ratio | -8.9 |
|---|---|
| PEG | 23.48 |
| Price to Sales | - |
| Price to Book Ratio | -19.51 |
| Enterprise Value to Revenue | 73.21 |
| Enterprise Value to EBIT | -11.85 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | -3.97 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS
-$1.37
Est. -$1.43Revenue
$47.56 M
Est. $41.88 MNext Earnings Call
Expected Date
February 23, 2027
EPS Estimate
-$1.41
Consensus analyst estimateRevenue Estimate
$64.28 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 1.00, calls and puts are about even.
| Put/Call Ratio | 1.0000▲ 83.17% |
|---|---|
| Total Calls | 18,000▼ 99.72% |
| Total Puts | 18,000▼ 98.32% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 11.50%▼ 111.12% |
|---|---|
| Total Invested | $1.00B▼ 92.74% |
| Investors Holding | 182▼ 333.00% |
About Cytokinetics Inc
CEO: Robert Blum
